Gene · 6510
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Optimized peptide nanofibrils as efficient transduction enhancers for in vitro and ex vivo gene transfer. | Front Immunol | 2023 | 38022685 | PubTator, text mining | PubMed |
| Identification of A Novel Gene Signature Combining Ferroptosis- and Immunity-Related Genes for Prognostic Prediction, Immunotherapy and Potential Therapeutic Targets in Gastric Cancer. | J Cancer | 2023 | 38021154 | PubTator, text mining | PubMed |
| The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade. | Front Cell Dev Biol | 2023 | 38020920 | PubTator, text mining | PubMed |
| Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies. | Cell Biochem Funct | 2023 | 38014635 | PubTator, text mining | PubMed |
| Single VHH-directed BCMA CAR-NK cells for multiple myeloma. | Exp Hematol Oncol | 2023 | 38012722 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapies for psoriasis. | Signal Transduct Target Ther | 2023 | 38008779 | PubTator, text mining | PubMed |
| Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance. | Pharmaceutics | 2023 | 38004589 | PubTator, text mining | PubMed |
| Controlling Trophoblast Cell Fusion in the Human Placenta-Transcriptional Regulation of Suppressyn, an Endogenous Inhibitor of Syncytin-1. | Biomolecules | 2023 | 38002309 | PubTator, text mining | PubMed |
| The Effects of Deregulated Ribosomal Biogenesis in Cancer. | Biomolecules | 2023 | 38002277 | PubTator, text mining | PubMed |
| Phytochemicals Target Multiple Metabolic Pathways in Cancer. | Antioxidants (Basel) | 2023 | 38001865 | PubTator, text mining | PubMed |
| Targeting ferroptosis in melanoma: cancer therapeutics. | Cell Commun Signal | 2023 | 37996827 | PubTator, text mining | PubMed |
| Evaluating the Effect of Gestational Exposure to Perfluorohexane Sulfonate on Placental Development in Mice Combining Alternative Splicing and Gene Expression Analyses. | Environ Health Perspect | 2023 | 37995155 | PubTator, text mining | PubMed |
| Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective. | Cancer Cell Int | 2023 | 37993909 | PubTator, text mining | PubMed |
| Characterization of a fluorescence imaging probe that exploits metabolic dependency of ovarian clear cell carcinoma. | Sci Rep | 2023 | 37985723 | PubTator, text mining | PubMed |
| Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes. | Open Res Eur | 2023 | 37981907 | PubTator, text mining | PubMed |
| Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37981648 | PubTator, text mining | PubMed |
| SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer. | Cell Rep | 2023 | 37980563 | PubTator, text mining | PubMed |
| Iron derived from NCOA4-mediated ferritinophagy causes cellular senescence via the cGAS-STING pathway. | Cell Death Discov | 2023 | 37980349 | PubTator, text mining | PubMed |
| EphA2 as a phase separation protein associated with ferroptosis and immune cell infiltration in colorectal cancer. | Aging (Albany NY) | 2023 | 37980165 | PubTator, text mining | PubMed |
| Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression. | BMC Cancer | 2023 | 37978473 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6510/papers?page=20